http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cee4729de3854055c00bb5f9772e13a6
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Raffeld |
| name | Mark. Raffeld Mark Raffeld |
| given-name | Mark. Mark |
| organization-name | Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD National Cancer Institute (NCI) Laboratory of Pathology, NIH, Bethesda, MD; Affiliations of authors: Laboratory of Cellular Oncology (DS-M, HQ, HO, GT), HIV and AIDS Malignancy Branch (TSU, MNP, KMW, KA, VW, RY), Women's Malignancies Branch (CMA), Laboratory of Pathology (MR), Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical, Frederick National Laboratory for Cancer Resear Laboratory of PathologyNational Institutes of HealthBethesdaMaryland20892–1500USA Laboratory of Pathology, Hematopathology section, NCI, NIH, Bethesda, MD 20892, USA Laboratory of Pathology National Cancer Institute, Clinical Center, National Institutes of Health Bethesda Maryland USA 1Molecular Diagnostics Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Molecular Pathology Section, Pathology Branch, Division of Clinical Sciences, National Cancer Institute, NIH, Bethesda, MD From the Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD; Laboratory of Pathology, Hematopathology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD; and Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD. Laboratory of Pathology, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH Departments of Anatomy, Physiology, and Genetics, and Institute for Molecular Medicine, and Center for Prostate Disease Research, and Department of Surgery, Uniformed Services University School of Medicine, Bethesda, MD 20814; Section on Molecular Genetics, Cancer Genetics Branch, National Human Genome Research Institute, and Laboratory of Pathology, Hematopathology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Laboratory of Cancer Genetics, Tampere ... Molecular Diagnostics and Bioinformatics, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD Hematopathology Section, The National Cancer Institute, 10/2N202, 10 Center Drive, Bethesda, MD 20892-1500, USA Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA 2Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. From the Medicine Branch, National Cancer Institute, Division of Clinical Sciences, National Institutes of Health, Bethesda, MD; Center for Biologics Evaluation and Research, Rockville, MD; and Laboratory of Pathology, National Cancer Institute, Division of Clinical Science, National Institutes of Health, Bethesda, MD. Molecular Diagnostics Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD; National Institute of Diabetes and Digestive and Kidney Diseases, and Hematopathology Section, Laboratory of Pathology, National Cancer Institute (M.R.), National Institutes of Health, Bethesda, Maryland 20892 Ariel Lopez-Chavez, Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Anish Thomas, Moses O. Evbuomwan, Liqiang Xi, Guinevere Chun, Arun Rajan, Mark Raffeld, Seth M. Steinberg, and Giuseppe Giaccone, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Tatiana Vidaurre, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Oscar Arrieta, Instituto Nacional de Cancerologia, Mexico City, Mexico; George Oblitas III, Hospital... 4Special Diagnostics Section and Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA Laboratory of Pathology, National Cancer Institute, Bethesda, MD Authors' Affiliations: 1Experimental Transplantation and Immunology Branch; 2Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland; and 3Division of Neurosurgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina Laboratory of Pathology National Cancer Institute Bethesda MD USA Laboratory of Pathology National Cancer Institute National Institutes of Health Bethesda Maryland USA 1National Cancer Institute-Food and Drug Administration Clinical Proteomics Program, Laboratory of Pathology, and Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, MD; 3Laboratory of Pathology, NIH, National Cancer Institute, Bethesda, Maryland. Laboratory of Pathology, Center for Cancer Research National Cancer Institute (NCI), National Institutes of Health (NIH) Bethesda Maryland USA From Hematopathology Section, Laboratory of Pathology, National Cancer Institute and Immunoregulation of Human Lymphocyte Function Unit, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and the Department of Pathology, Albert Szent-Gyorgyi Medical University, Szeged, Hungary. From the Institute of Pathology, GSF–National Research Center for Health and Environment, Neuherberg, Germany; the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD; and the Department of Internal Medicine III and the Institute of Pathology, Technical University Munich, Germany. National Institutes of Health, Bethesda, MD Laboratory of Pathology Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD USA Molecular Diagnostics, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 1Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892; Authors' Affiliations: Laboratories of 1Molecular Biology, 2Pathology, and 3Metabolism Branch, National Cancer Institute; and 4Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, Maryland From the Cell and Cancer Biology Branch and Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD; and Department of Pathology, Hospital del Mar, Barcelona, Spain. From the Medicine Branch and Laboratory of Pathology, National Cancer Institute, Bethesda, MD. 4National Cancer Institute; and From the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD. From the Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Belhesda, Maryland Authors' Affiliations: 1National Cancer Institute-Center for Cancer Research; 2Suburban Hospital; 3Eunice Kennedy Shriver NICHD, Bethesda, Maryland; 4University of Utah, Salt Lake City, Utah; 5Illumina, Inc., San Diego, California; 6Dana Farber Cancer Institute, Boston, Massachusetts; 7Our Lady's Children's Hospital, Dublin, Ireland Laboratory of Pathology, National Cancer Institute, National Institute of Health, Bethesda MD 20892, USA Laboratory of Pathology, National Cancer Institute Bethesda USA 2Hematopathology Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. Laboratory of Pathology, National Cancer Institute (NCI), Bethesda, MD; From the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, and Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Department of Pathology, Instituto Nacional de la Nutrición, México City, México; Institute for Pathology, GSF-Research Center for Environment and Health, Neuherberg, Germany. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and Laboratory of Pathology 6 and 7; Metabolism Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892 6 and 7 James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert P.T. Somerville, Robert O. Carpenter, Maryalice Stetler-Stevenson, James C. Yang, Q. Phan, Marybeth S. Hughes, Richard M. Sherry, Mark Raffeld, Steven Feldman, Lily Lu, Yong F. Li, Lien T. Ngo, Debbie-Ann N. Nathan, Kathleen E. Morton, Mary Ann Toomey, and Steven A. Rosenberg, National Cancer Institute; Clara C. Chen, Clinical Center, National Institutes of Health (NIH); Sarah M. Kranick and Avindra Nath, National Institutes of Neurologic... From the Hematopathology Section, Laboratory of Pathology; and the Molecular Therapeutics Program, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD; the Laboratory of Proteomics and Analytical Technologies, Science Applications International Corporation (SAIC)-Frederick, MD; the Institute of Pathology, Technical University of Munich, Germany; and the Gesellschaft für Strahlenforschung (GSF)-National Research Center for Health and Environment, Neuherberg, Germany. Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Authors' Affiliations: 1Center for Cancer Research, 2Laboratory of Pathology, National Cancer Institute; 3National Institute of Dental and Craniofacial Research, Bethesda, Maryland; 4Washington University School of Medicine, St. Louis, Missouri; and 5Dipartimento di Biologia e Patologia Cellulare e Molecolare, Universitá di Napoli Federico II, Napoli, Italy Laboratory of Pathology and From the Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics; the Biostatistics and Data Management Section, Center for Cancer Reseach; the Hematopathology Section; and the Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD. Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA Laboratory of Pathology, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland USA Laboratory of Pathology Center for Cancer Research National Cancer Institute Bethesda MD USA From the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD; Institute of Pathology, GSF-National Research Center for Environment and Health, Neuherberg, Germany; Institute of Pathology, Technical University, Munich, Germany; and the Hospital Clinic Provincial, University of Barcelona, Barcelona, Spain. Laboratory of Pathology, National Cancer Institute; National Institutes of Health, Bethesda, MD 20902, USA. Laboratory of Pathology, CCR, NCI, NIH, Bethesda, MD 20892; Authors' Affiliations: 1Center for Cancer Research and 2Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland; 3Clinical Monitoring Research Program and 4Applied/Developmental Research Support Directorate, Science Applications International Corporation-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland From the Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD. From the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland. From the Center for Cancer Research, Bethesda, MD; Massachusetts General Hospital, Boston, MA; and the University of Connecticut, Hartford, CT Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; From the Laboratory of Clinical Investigation, Clinical Research Training Program, and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Laboratory of Pathology, National Cancer Institute, National Human Genome Research Institute, and Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland; and SAIC, Inc, Frederick, Maryland. From the Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD. 5Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda 1SAIC-Frederick, Inc., and 2Developmental Therapeutics Program, National Cancer Institute at Frederick, Frederick, Maryland; and 3Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland From the Neuroimmunology Clinic (I.C., J.O.) and the Neuroimmunological Diseases Unit (B.B.), National Institute of Neurological Disorders and Stroke, and the Laboratory of Pathology (C.-C.L., M.R.) and the Dermatology Branch (E.W.C., J.J.D.), Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda; and Department of Neurology (K.F.), Johns Hopkins School of Medicine, Baltimore, MD. Ariel Lopez-Chavez, Anish Thomas, Arun Rajan, Mark Raffeld, Betsy Morrow, Ronan Kelly, Corey Allan Carter, Udayan Guha, Keith Killian, Christopher C. Lau, Zied Abdullaev, Liqiang Xi, Svetlana Pack, Paul S. Meltzer, David J. Liewehr, Seth M. Steinberg, Arlene Berman, Eva Szabo, Yisong Wang, and Giuseppe Giaccone, National Cancer Institute; Austin Doyle, Cancer Therapy Evaluation Program, Bethesda, MD; Ariel Lopez-Chavez, Christopher L. Corless, Alan Sandler, Carol Beadling, and Andrea Warrick, Knight... 1Hematopathology Section, Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland and From the Center for Cancer Research, National Cancer Institute, Bethesda, MD; Holy Cross Hospital, Ft Lauderdale, FL; St Luke's-Roosevelt Hospital and Beth Israel Medical Center, New York, NY; National Institute on Aging, Baltimore, MD; and Massachusetts General Hospital, Boston, MA. From the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD; and Gene Cloning & Analysis, Clontech Laboratories, Palo Alto, CA. From the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD; and the Department of Pathology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; From the Hematopathology Section, Laboratory of Pathology, National Cancer Institute and the B cell Molecular Immunology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and the Department of Pathology, Albert Szent-Gyorgyi Medical University, Szeged, Hungary. Laboratory of Pathology, National Cancer Institute, Bethesda, MD; and Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD; and Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA National Institutes of Health, National Cancer Institute Laboratory of Pathology Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892 2Hematopathology Section, Laboratory of Pathology, National Cancer Institute, 1Surgery Branch, Center for Cancer Research, National Cancer Institute (NCI), US National Institutes of Health (NIH), Bethesda, Maryland. Laboratory of Pathology, National Cancer Institute, Bethesda, MD; Molecular Diagnostics Unit, Laboratory of Pathology, National Cancer Institute, Bethesda, MD 7Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Laboratory of Pathology, Hematopathology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. From the National Institutes of Health, National Cancer Institute, Bethesda, MD. Laboratory of Pathology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 2Laboratory of Pathology, NIH/National Cancer Institute; Authors' Affiliations: 1Cell and Cancer Biology Branch, 2Antibody and Protein Purification Unit, and 3Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD, USA Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 2Molecular Diagnostics, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD From the Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD Authors' Affiliation: Laboratories of Molecular Biology and Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 2Laboratory of Pathology, 3Laboratory of Pathology, Hematopathology Section, National Cancer Institute, NIH, Bethesda, Maryland; Authors' Affiliations: 1Medical Oncology Branch and 2Genetics Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI); 3Department of Nuclear Medicine and Radiology, Clinical Center, NIH; 4Laboratory of Pathology, and 5Biostatistics and Data Management Section, CCR, NCI; and 6Cancer Therapy Evaluation Program, NCI, Bethesda, Maryland Laboratory of Pathology, National Cancer Institute, National Institutes of Health 2Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. Laboratory of Pathology, NCI, Bethesda, MD; Molecular Diagnostics Section, Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, MD; |
Incoming Links
Showing number of triples: 1 to 429 of 429.